Comparing Budesonide vs Salbutamol
Budesonide | Salbutamol |
|
---|
Budesonide | Salbutamol |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Inflammatory Bowel Disease, Crohn's Disease, Asthma, Autoimmune Hepatitis, Eosinophilic Esophagitis, Asthma - Maintenance, Crohn's Disease - Active, Immunoglobulin A Nephropathy... View more |
Prescription only
Prescribed for Asthma. Salbutamol may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
More about Budesonide | More about Salbutamol | ||||||||
Ratings & Reviews | |||||||||
Budesonide has an average rating of 6.8 out of 10 from a total of 177 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 18% reported a negative effect. |
Salbutamol has an average rating of 7.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Budesonide side effects |
|||||||||
Drug Class | |||||||||
None |
|||||||||
Generic Availability | |||||||||
Lower cost generic |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Budesonide prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Entocort EC, Eohilia, Pulmicort Flexhaler, Pulmicort Respules, Tarpeyo, Uceris |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
2.8 hours |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Unknown
CSA Schedule is unknown. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. |
||||||||
Drug Interactions | |||||||||
A total of 565 drugs are known to interact with Budesonide:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
First Approval Date | |||||||||
October 02, 2001 |
N/A |
||||||||
WADA Class View classifications | |||||||||
More Information | |||||||||
|
|||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Tarpeyo
Tarpeyo (budesonide) is an oral, delayed-release, corticosteroid capsule that may be used to reduce ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Filspari
Filspari is used for primary immunoglobulin A nephropathy (IgAN), to slow kidney function decline ...
Omvoh
Omvoh is used to treat moderate to severe ulcerative colitis or Crohn's disease in adults. This ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Xolair
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.